Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rationale for prescribing oral contraceptives]

A T Teichmann1

  • 1Klinikum Aschaffenburg, Deutschland.

Wiener Medizinische Wochenschrift (1946)
|August 13, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015)

Geburtshilfe und Frauenheilkunde·2016
Same author

The Prevention of Positioning Injuries during Gynecologic Operations. Guideline of DGGG (S1-Level, AWMF Registry No. 015/077, February 2015).

Geburtshilfe und Frauenheilkunde·2015
Same author

Diagnostic approach and therapeutic management in early-stage endometrial cancer.

European journal of gynaecological oncology·2013
Same author

A retrospective analysis of twenty-eight borderline ovarian tumours in adolescent girls.

European journal of gynaecological oncology·2009
Same author

Laparoscopic treatment of ovarian dermoid cysts.

Clinical and experimental obstetrics & gynecology·2008
Same author

Uterine sarcoma: a report of 57 cases over a 16-year period analysis.

European journal of gynaecological oncology·2008

Choosing oral contraceptives (OC) involves considering non-contraceptive benefits alongside efficacy. Individual patient conditions, like hyperandrogenism, guide the selection of progestogens and ethinylestradiol doses for optimal outcomes.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Gynecology

Context:

  • Oral contraceptives (OC) are widely prescribed for contraception and various gynecological conditions.
  • Numerous OC formulations exist, necessitating a structured approach to selection.
  • Individual patient characteristics significantly influence treatment outcomes.

Purpose:

  • To outline strategies for optimizing oral contraceptive prescription.
  • To highlight the importance of non-contraceptive benefits in OC selection.
  • To provide guidance on managing OC therapy based on patient-specific factors.

Summary:

  • Prescribing oral contraceptives (OC) requires careful consideration of individual patient conditions to optimize selection.
  • Non-contraceptive benefits, such as antiandrogenic effects of specific progestogens (e.g., cyproterone acetate), are crucial decision-making criteria.
Keywords:
AndrogensBiologyContraceptionContraceptive Method SwitchingContraceptive MethodsContraceptive UsageCyproterone AcetateDeveloped CountriesDistributional ActivitiesEndocrine SystemEuropeFamily PlanningGermanyHormone AntagonistsHormonesOral ContraceptivesOral Contraceptives, CombinedOral Contraceptives, Low-doseOrganization And AdministrationPhysiologyPrescriptionsProgram ActivitiesProgramsRecommendationsWestern Europe

Related Experiment Videos

  • Estrogenicity and progestogen potency influence non-contraceptive effects in non-androgen-related conditions.
  • Initiate treatment with the lowest effective doses and continue for 3-4 cycles, adjusting dose or regimen for persistent issues without changing the progestogen.

    • Impact:

    • Facilitates personalized oral contraceptive prescribing for improved efficacy and patient satisfaction.
    • Enhances the management of conditions like hyperandrogenism through targeted OC selection.
    • Provides a framework for dose titration and regimen adjustment to minimize adverse effects and ensure treatment adherence.